Array BioPharma Inc. (NASDAQ:ARRY) reported a loss of $8.6 million in its fiscal second quarter. On a per-share basis, the Boulder, Colorado-based company said it had a loss of 6 cents. The results topped Wall Street expectations. The average estimate of analysts surveyed by Zacks Investment Research was for a loss of 20 cents per share. On Wednesday shares of Array BioPharma, Inc. (NASDAQ:ARRY) closed at $7.32. Company’s sales growth for last 5 years was 11.00% and EPS growth for next 5 years is recorded as 10.00%.
Evogene Ltd. (NYSE: EVGN) announced that its recently developed comprehensive gene optimization program is being incorporated into its multi-year collaboration with Monsanto Company (NYSE: MON). Evogene Ltd. (NYSE:EVGN) in last trading activity increased 10.27% to close at $9.34. Company weekly performance is 12.80% while its quarterly performance stands at -16.23%. Evogene Ltd. (NYSE:EVGN) is -53.30% away from its 52 week high.
Alamos Gold Inc. (NYSE:AGI) plans to release its fourth quarter and year-end 2014 financial results before the start of trading on Thursday, February 19, 2015. Senior management will host a conference call at 12:00 pm ET on that day to discuss the results. On last trading day Alamos Gold Inc. (NYSE:AGI) increased 5.30% to close at $5.76. Its volatility for the week is 5.59% while volatility for the month is 7.42%. AGI’s EPS growth for past 5 years was -34.46%. Alamos Gold Inc. (NYSE:AGI) monthly performance is -27.46%.
On January 26, 2015, Tiptree Operating Company, LLC the subsidiary through which Tiptree Financial Inc. (NASDAQ:TIPT) conducts its operations, entered into a First Amendment (the “Amendment”) to its Credit Agreement dated as of September 18, 2013 by and among Operating Subsidiary, as borrower, the lenders party thereto from time to time and Fortress Credit Corp., as administrative agent, collateral agent and lead arranger (as amended by the Amendment, the “Credit Agreement”). Tiptree Financial Inc. (NASDAQ:TIPT) has 7.40% insider ownership while its institutional ownership stands at 32.40%. In last trading activity company’s stock closed at $7.30.
The Advisory Board Company (NASDAQ:ABCO) announced that it will hold a conference call hosted by Robert W. Musslewhite, Chief Executive Officer and Michael T. Kirshbaum, Chief Financial Officer, to discuss the Company’s financial results for the quarter and nine-month transition period ended December 31, 2014. The call will be held on Wednesday, February 11, 2015, at 5:30 p.m., Eastern Time. On last trading day The Advisory Board Company (NASDAQ:ABCO) moved down -0.60% to close at $49.45. Its volatility for the week is 3.64% while volatility for the month is 3.89%. ABCO’s sales growth for past 5 years was 18.50% and its EPS growth for past 5 years was 0.30%. The Advisory Board Company (NASDAQ:ABCO) monthly performance is 1.37%.